Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19.

ABSTRACT:

Background

With the persistent COVID-19 pandemic, there is an urgent need to use rapid and reliable diagnostic tools for highly urgent cases. Antigen tests are disappointing with their lack of sensitivity. Among molecular tools allowing a diagnosis in less than an hour, only one, the Cepheid Xpert Xpress SARS-CoV-2 assay, has exhibited a good sensitivity. However, we are also facing a global shortage of reagents and kits. Thus, it is imperative to evaluate other point-of-care molecular tests.

Methods

We evaluated the VitaPCR™ RT-PCR assay, whose sample analysis time is of approximately 20 min, in nasopharyngeal secretions from 534 patients presenting to our Institute, for the diagnosis of COVID-19, and compared it to our routine RT-PCR assay. We also compared the two assays

SUBMITTER: Fournier PE 

PROVIDER: S-EPMC7598902 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature